Zhongnan Medical Journal Press

Home Results

A total of 6 result was found. Results that relate to Camrelizumab

A case report of immunotherapy-related breast reactive capillary endothelial proliferation

Published on New Medicine 2023,33(1):74-77.
2767 times 1032 times

Chen JIE Jing YU Ru-Meng LI Jun GONG Cong-Hua XIE

Reactive capillary endothelial proliferation Breast Immunotherapy Camrelizumab
Details
Pharmaceutical care of rare immune-related abducens nerve adverse events induced by camrelizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1305-1310.
3024 times 1075 times

Ren-Pei LIANG Guan LIN Zhang-Chao LAI

Camrelizumab Abducens nerve palsy Adverse drug reaction Pharmaceutical care
Details
Evaluation of the efficacy and safety of Camrelizumab combined with Shenqi Fuzheng injection in the treatment of advanced non-squamous non-small cell lung cancer patients

Published on Frontiers in Pharmaceutical Sciences 2023,36(11):241-248.
2348 times 761 times

Wen-Ze SUN Ying-Bing ZHANG Lin WANG

Advanced non-squamous non-small cell cancer Camrelizumab Shenqi Fuzheng injection
Details
Efficacy and safety of camrelizumab combined with apatinib in the treatment of triple-negative breast cancer: a Meta-analysis and systematic review

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1137-1146.
2842 times 600 times

NIU Zhaofeng ZHAI Yanghai GENG Rui

Camrelizumab Apatinib Triple-negative breast cancer Meta-analysis Systematic review
Details
Literature analysis of adverse reactions to multiple organ injury induced by camrelizumab

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):648-656.
3401 times 337 times

ZHANG Yang SU Wenyang GAO Yue

Camrelizumab Multiple organ injury Adverse reactions Literature system analysis Immunotherapy Programmed death protein 1
Details
Clinical pharmacist participated in a case study of a severe immune-related cholestatic liver injury case induced by camrelizumab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):341-345.
2156 times 307 times

YUWEN Lixia HE Yunhao YUAN Yaohui

Clinical pharmacist Camrelizumab Liver injury Cholestatic Immunotherapy
Details